Highlights
- High prevalence of immunosuppression has been found among adults in US.
- Immunosuppression increases the risks and severity of primary or reactivation infections.
- The findings are important as it will help to assess immunosuppressive treatments for prevention or mitigation of common chronic diseases in highly prevalent risk groups. The number of immunosuppressed adults in the United States is thought to be increasing because of both greater life expectancy among immunosuppressed adults due to improvements in medical management, as well as new indications for immunosuppressive treatments. Immunosuppression increases the risks and severity of primary or reactivation infections.
About AIDS/HIV - Prevention And Transmission
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV
‘The life expectancy of immunosuppressed individuals is increasing due to improvements in medical management, as well as new indications for immunosuppressive treatments.’
Tweet it Now
In a study published online by JAMA, Rafael Harpaz, M.D., M.P.H., of the U.S. Centers for Disease Control and Prevention, Atlanta, and colleagues analyzed data from the 2013 National Health Interview Survey (NHIS; an annual health survey conducted via household interviews).The researchers estimated the prevalence of self-reported immunosuppressed adults in the United States.
The prevalence of immunosuppression has implications for food and water safety, tuberculosis control, vaccine programs, infection control strategies, outbreak preparedness, travel medicine, and other facets of public health.
Nanomedicine Hopes to Improve HIV Drug Treatment
Novel nanotherapy approach hopes to reduce drug dosage and costs of HIV treatment, including improvement of existing pediatric therapeutic options.
Novel nanotherapy approach hopes to reduce drug dosage and costs of HIV treatment, including improvement of existing pediatric therapeutic options.
If the respondents said “yes”, they were asked follow-up questions to assess whether that status was current (i.e., at time of response) and to report additional evidence of immunosuppression.
Advertisement
Initial HIV Care at Home may Increase Use of ART
Offering optional home care initiation after HIV self testing could be linked to a significant increase in the number of adults initiating antiretroviral therapy compared to standard HIV care
Offering optional home care initiation after HIV self testing could be linked to a significant increase in the number of adults initiating antiretroviral therapy compared to standard HIV care
On the other hand those reporting only frequent colds or infections or attributing immunosuppression solely to chronic diseases or to solid cancers (i.e., in absence of immunosuppressive treatments) were not considered immunosuppressed.
Advertisement
Quiz on HIV Symptoms
Do you know that there are symptoms for each stage of HIV/AIDS? Learn more from our HIV Symptom Quiz but here’s a disclaimer – never go by symptoms alone. Symptoms only indicate the progression of the disease, while only a medical test can confirm it.
Do you know that there are symptoms for each stage of HIV/AIDS? Learn more from our HIV Symptom Quiz but here’s a disclaimer – never go by symptoms alone. Symptoms only indicate the progression of the disease, while only a medical test can confirm it.
Of 34,426 eligible adult respondents within these households, 4.2% (n = 1,442) had been told at some time by a health professional that their immune system was weakened.
Of these, 2.8% (n = 951) reported current immunosuppression and additional evidence of immunosuppression.
The prevalence of immunosuppression in US adults was estimated to be at 2.7%.
Prevalence was highest among women, whites, and persons age 50 to 59 years.
"This study was not designed to explore the attributable causes of immunosuppression, although prevalence is likely driven by frequency and chronicity (e.g., life-long immunosuppression due to HIV infection, treatment for autoimmune conditions, or solid organ transplantation vs short-term cancer chemotherapy). The higher prevalence of immunosuppression among women may reflect their higher risk for autoimmune conditions. Age-specific immunosuppression increased with age, in parallel with the epidemiology of prevalent conditions that require immunosuppressive treatments, but it is unclear why it peaked at ages 50 to 59 years," the authors write.
This study addresses an underappreciated phenomenon and serves as a call for additional data from other sources to complement and fill the gaps in the study.
Tracking immunosuppression over time is particularly important given the hundreds of clinical trials now under way to assess the use of immunosuppressive treatments for prevention or mitigation of common chronic diseases in highly prevalent risk groups.
Source-Medindia
